Lack of difference in overall tumor burden but evidence of decreased tumor latency in response to chemical carcinogens in Inv-Dsg2/Ptc1+/lacZ mice, suggests a possible synergistic effect of the two pathways on the rate of tumor promotion. The gene discussed is DSG2; the disease is neoplasm.